GOING BEYOND EVERY DAY
Live / Registered — Registered (as of 04 Mar 2025)
What this means for you
Registered since 04 Mar 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97778742
- Registration number
- 7716108
- Mark type
- Stylized text
- Filed
- 02 Feb 2023
- Published for opposition
- 28 Nov 2023
- Registered
- 04 Mar 2025
- Attorney of record
- Brian Focarino
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy biomedical research in the field of gene therapy design and delivery; gene therapy research, namely, design and delivery development of biochemical assays; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific, medical, and pharmaceutical research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery; medical and scientific research, namely, compiling and sharing of patient data for research purposes in the field of rare diseases and disorders; providing medical and scientific research information in the field of rare diseases and disorder
Owner
- Ultragenyx Pharmaceutical Inc., Novato, CA, US
- Ultragenyx Pharmaceutical Inc., Novato, CA, US
- Ultragenyx Pharmaceutical Inc., Novato, CA, US
Prosecution history
- 04 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 04 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Feb 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Nov 2024 — USE AMENDMENT FILED
- 11 Feb 2025 — SOU EXTENSION 2 GRANTED
- 26 Nov 2024 — SOU EXTENSION 2 FILED
- 10 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Nov 2024 — TEAS STATEMENT OF USE RECEIVED
- 26 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 02 Aug 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 02 Aug 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED